DERM
Dermira Inc
Halal Rating :
Last Price
$3.71
Last updated:
Market Cap
-
7D Change
-1.96%
1 Year Change
-30.99%
Company Overview
Industries
Exchange
Next Earnings Date
Dermira Inc was a biopharmaceutical company focused on developing innovative therapies for chronic skin conditions. The company was acquired by Eli Lilly and Company (LLY) in February 2020 for approximately $1.1 billion. All DERM shares were converted to LLY shares at that time.
Since this company no longer exists as a separate entity and is now part of Eli Lilly (LLY), investors interested in this space should evaluate LLY instead.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $14.63m | $17.16m | - | $-367000.0 | 0.00% | 2.14% |
| June 30, 2024 | $14.86m | $18.34m | - | $563000.0 | 0.00% | 3.07% |
| March 31, 2024 | $13.03m | $23.67m | - | $548000.0 | 0.00% | 2.32% |
Company Impact
Help us evaluate Dermira Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.